Leukotrienes are potent constrictors of human bronchi
- PMID: 6108512
- DOI: 10.1038/288484a0
Leukotrienes are potent constrictors of human bronchi
Abstract
Slow reacting substance of anaphylaxis (SRS-A) is released by various stimuli, including immunological challenge, and has long been considered an important mediator of immediate hypersensitivity reactions, such as bronchoconstriction in allergic asthma. Recently, slow reacting substances from several tissues have been identified and characterized as members of a newly discovered group of substances, the leukotrienes. Leukotrienes are generated from arachidonic acid and other polyunsaturated fatty acids in a pathway initially involving a lipoxygenase-catalysed oxygenation at C-5 (Fig. 1). This differs from the synthesis of prostaglandins and thromboxanes, where the initial transformation of arachidonic acid is catalysed by a cyclo oxygenase (Fig. 1). Recently, leukotriene C4(LTC4:5(S)-hydroxy,6(R)-S-glutathionyl-7,9-trans, 11,14-cis-eicosatetraenoic acid) and D4(LTD4:5(S)-hydroxy,6(R)-S-cysteinyl-glycyl-7,9-trans,11,14-cis-eicosatetraenoic acid) were found to have biological effects in several bioassay systems, which are strikingly similar to those previously reported for impure extracts of SRS-A. Here we report the remarkable contractile activity of both LTC4 and LTD4 on isolated human bronchi, which further emphasizes the possibility that leukotrienes are potent mediators of bronchoconstriction in man.
Similar articles
-
The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat.Prostaglandins. 1981 May;21(5):793-803. doi: 10.1016/0090-6980(81)90236-7. Prostaglandins. 1981. PMID: 6122236
-
Leukotrienes.Annu Rev Biochem. 1983;52:355-77. doi: 10.1146/annurev.bi.52.070183.002035. Annu Rev Biochem. 1983. PMID: 6311078 Review.
-
Prostaglandins, thromboxanes, and leukotrienes in inflammation.Am J Med. 1986 Apr 28;80(4B):11-7. doi: 10.1016/0002-9343(86)90073-2. Am J Med. 1986. PMID: 2871754
-
Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro.Nature. 1981 Mar 26;290(5804):343-4. doi: 10.1038/290343a0. Nature. 1981. PMID: 6111025
-
Leukotrienes: possible mediators in bronchial asthma.Eur J Respir Dis Suppl. 1983;129:45-64. Eur J Respir Dis Suppl. 1983. PMID: 6317422 Review.
Cited by
-
Evidence indicating that leukotrienes C4, D4 and E4 are major mediators of contraction induced by anti-IgE in human bronchi.Agents Actions. 1989 Jan;26(1-2):87-9. doi: 10.1007/BF02126568. Agents Actions. 1989. PMID: 2540649 No abstract available.
-
Pharmacological studies of pulmonary anaphylaxis in vitro: a review.Agents Actions. 1985 Dec;17(2):158-74. doi: 10.1007/BF01966586. Agents Actions. 1985. PMID: 2420161 Review. No abstract available.
-
Leukotriene receptor antagonist therapy.Postgrad Med J. 2000 Dec;76(902):767-73. doi: 10.1136/pmj.76.902.767. Postgrad Med J. 2000. PMID: 11085767 Free PMC article. Review.
-
Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2256-61. doi: 10.1073/pnas.041624398. Epub 2001 Feb 13. Proc Natl Acad Sci U S A. 2001. PMID: 11226226 Free PMC article.
-
Montelukast use over the past 20 years: monitoring of its effects and safety issues.Clin Exp Pediatr. 2020 Oct;63(10):376-381. doi: 10.3345/cep.2019.00325. Epub 2020 Feb 5. Clin Exp Pediatr. 2020. PMID: 32023405 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
